Arrow Mark Colorado Holdings LLC Argenx Se Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $8.13 Million - $9.66 Million	-27,549 Reduced 94.37%	1,645 $497,000
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $6.2 Million - $7.72 Million	-24,121 Reduced 45.24%	29,194 $8.79 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $717,702 - $1.02 Million	-2,675 Reduced 4.78%	53,315 $14.7 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $585,338 - $727,421	-2,359 Reduced 4.04%	55,990 $16.5 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $9.64 Million - $12.2 Million	-44,719 Reduced 43.39%	58,349 $15.3 Million
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $3.52 Million - $6.42 Million	-27,590 Reduced 21.12%	103,068 $23.2 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $80,207 - $121,774	737 Added 0.57%	130,658 $17.2 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $668,532 - $1.03 Million	6,272 Added 5.07%	129,921 $20.9 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $31,726 - $42,142	280 Added 0.23%	123,649 $14.1 Million
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $3.68 Million - $4.53 Million	-32,026 Reduced 20.61%	123,369 $17.5 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $2.23 Million - $3.03 Million	-22,528 Reduced 12.66%	155,395 $19.4 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $222,058 - $382,173	3,480 Added 1.99%	177,923 $17.1 Million
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $594,940 - $761,444	-7,880 Reduced 4.32%	174,443 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $521,784 - $698,315	6,972 Added 3.98%	182,323 $15.1 Million
Q1 2018 May 15, 2018	SELL	$56.95 - $85.19 $2.01 Million - $3.01 Million	-35,365 Reduced 16.78%	175,351 $14.1 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $4.76 Million - $13.4 Million	210,716	210,716 $13.3 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.67 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$780 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account